indication for semaglutide A New (Wegovy) https://bit.ly/3UmgXaj The injectable glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy) has been approved by the FDA to reduce the risk… Use of semaglutide linked to

[2] Tran D, Nguyen V, Breck M, Phinney B, Weber D

The hair loss signal Pharmacovigilance data have moved hair loss from anecdote to defined signal

An intervention resembling caloric restriction prolongs life span and retards aging in yeast

A very recent study in healthy European volunteers assessed allulose effects at different doses on background of a 50-g sucrose test solution and observed a significant reduction of plasma glucose peaks at 30 min at the highest allulose doses of 75 and 10 g co-ingested with sucrose (Reference Franchi, Yaranov and Rollini38)

Black-out curtains, comfortable eye masks, and if needed, ear plugs may be good choices to put these problems to rest

Thus, Mounjaro (tirzepatide) has the potential for greater reduction in HbA1c levels over time when comnpared to semaglutide